-
Biotech updates 01/28:
$ARMP capital injection +74%$BHVN offering -10% AH$ALKS PDUFA Nov 15$REGN PDUFA May 26$BPMX &$CNAT reverse mergers$CERS offering$SAVA data mid-'20 +21%$HEPA +45% AH Pipeline updates$AKCA$INCY$NYMX$OTLK$PFE$SYRS$TFFP https://www.biopharmcatalyst.com/news/2020/armata-armp-capital-injection-74-biohaven-bhvn-offering-10-ah … -
After
$TFFP rang the@Nasdaq opening bell, President & CEO Glenn Mattes and Dr. Bill Williams sat down with@MarketJane of LilaMax Media to discuss our innovative technology and recent IPO. Watch the interview: http://bit.ly/2uoXYT3#drugdelivery#pharmapic.twitter.com/YizMjB44WF
-
- A small biotech that crystallizes insoluble medicines with their thin film freeze tech to directly hit affected portions of lungs - lot of insider buyings in the past months - quiet period over - buyout candidate?
$TFFP https://seekingalpha.com/news/3524970-tff-pharmaceuticals-reports-q3-results?source=feed_f&utm_campaign=twitter_automated&utm_content=news&utm_medium=social&utm_source=twitter … -
Attending
#JPM2020?$TFFP, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on our patented Thin Film Freezing platform, is open for#investor and#businessdevelopment meetings. https://bwnews.pr/2E8n3mY pic.twitter.com/S1utjI30OG
-
On Dec. 9th,
$TFFP reported our third quarter results. Q3 has been a time of key accomplishments for TFF Pharmaceuticals, including the successful completion of our $24M IPO on the@Nasdaq stock market. Read more: https://bwnews.pr/2E8CAmC#drugdelivery#pharmapic.twitter.com/qGNJ0v0gOJ
-
$TFFP: TFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA) -
LHS has been named
@TFFPharma's investor relations and corporate communications agency of record. We look forward to working with$TFFP to raise awareness for their breakthrough inhalable drug delivery platform. Read more: http://bit.ly/2O63f9s#IRpic.twitter.com/we3ACNNKha
-
Congratulations to
@TFFPharma who rang today's@Nasdaq opening bell!$TFFP is working to solve a major#drugdelivery challenge: that of poor water solubility & absorption. Listen to CEO Glenn Mattes' opening remarks and view the bell ringing here: http://bit.ly/2raFgNg pic.twitter.com/eSxRgWV0of
-
Congrats to our portfolio company Lung Therapeutics Inc’s spin-off
@TFFPharma for ringing the opening bell this morning!$TFFP pic.twitter.com/6TrvpKydJx
-
-
-
6 IPOs listing today!!!!
$AIH$CABA$PHAT$PGNY$DAO$TFFP follow@James_IPOSquawk and myself in http://www.awesomecalls.com for all IPO trading info today@AjTrader7 -
TFF Pharmaceuticals raises $22 million pricing IPO at $5
$TFFP$IPO#IPOhttp://zpr.io/tqPWw -
Exciting day for Bios — a spinout of one of our companies (Lung Therapeutics), TFF Pharma, announced the pricing of their IPO. Huge congrats to the whole team on this!
$TFFP https://www.businesswire.com/news/home/20191024006041/en/TFF-Pharmaceuticals-Prices-22-Million-Public-Offering … -
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.